We are investing resources to develop future products for the companion animal sector. Our business is currently concentrated in the livestock sector. Most of our administrative and management staff are working remotely. 8203; Certain amounts and percentages may reflect rounding adjustments. We sell our MFAs and other products in all regions where we do business. Our anticoccidial products include: • Nicarbazin.& & & We produce and market amprolium primarily as an active pharmaceutical ingredient. &# 8203; Anthelmintics are used to treat infestations of parasitic intestinal worms. To date, such bills have not had sufficient support to become law. In March 2018, the FDA indefinitely stayed the withdrawal proceedings. The 60-day comment period ends September 18, 2020. They are known as Brand Specific Approvals ("BSA"). The advice language states "authorities should prevent residues of carbadox in food. This can be accomplished by not using carbadox in food producing animals." We responded to the inspectional observation in writing in March 2015. International trade disputes and tariffs could reduce demand for our customers' products. As such, the use of new facilities also requires regulatory approvals. The supply of certain of our raw materials is dependent on third party suppliers. Certain of our employees are covered by collective bargaining or other labor agreements. See "Business — Environmental, Health and Safety." We are subject to risks from litigation that may materially impact our operations. As a result, our management's attention might be diverted from other business concerns.
